2 Patents
- US120233152024Pharmaceutical Compositions and Methods Utilizing Neostigmine and an NK-1 Antagonist for Treating Myasthenia Gravis
Somerset Therapeutics, LLC
0 cites - US117521412023Pharmaceutical Compositions and Methods Utilizing Neostigmine and an NK-1 Antagonist for Treating Myasthenia Gravis
DAS-MG, Inc.
0 cites